# EyePoint Pharmaceuticals, Inc. – FDA Inspection, Apr 4, 2018

Source: https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/0db9fefd-9ce7-4f02-8336-60414449746e
Source feed: FDA_Inspections

> FDA inspection 1046783 of EyePoint Pharmaceuticals, Inc., April 04, 2018. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046783
- Company Name: EyePoint Pharmaceuticals, Inc.
- Inspection Date: 2018-04-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1230113 - 2024-02-15](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/96011f71-7dc7-4d1e-af2a-8fb571d5f403)
- [FDA Inspection 1150669 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bc7824a1-722e-4a03-8af8-91a2affaaa96)
- [FDA Inspection 1102130 - 2019-08-28](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bd40ecfd-6d7a-4c39-8319-1d042041f48b)
- FDA Inspection 1067552 - 2018-09-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)
- [Company Rep](https://www.keypedia.com/people/steve-y-rhieu/3fdcdeab-f037-4fdb-a9f2-6eb58f4eede8)
- Issuing Officer

Company: https://www.keypedia.com/companies/eyepoint-pharmaceuticals-inc/ca6562a2-b315-4e33-b9b2-394c1c8ad945

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144